These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8881983)

  • 21. [Diagnosis and treatment recommendations for tic disorders in children].
    Subspecialty Group of Neurology, The Society of Pediatrics, Chinese Medical Association
    Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):72-5. PubMed ID: 23527937
    [No Abstract]   [Full Text] [Related]  

  • 22. Learning difficulties in children with Tourette syndrome.
    Singer HS; Schuerholz LJ; Denckla MB
    J Child Neurol; 1995 Jan; 10 Suppl 1():S58-61. PubMed ID: 7751556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation on the status of monotherapy for newly diagnosed tic disorders and its comorbidity in children].
    Lu Q; Cui YH; Liu ZS; Sun D; Fang F; Peng J; Zhou SZ; Wang JQ; Luo R; Jiang L; Qin J; Jiang YW; Zheng Y
    Zhonghua Er Ke Za Zhi; 2020 Nov; 58(11):887-892. PubMed ID: 33120459
    [No Abstract]   [Full Text] [Related]  

  • 24. Tics in Tourette syndrome: new treatment options.
    Awaad Y
    J Child Neurol; 1999 May; 14(5):316-9. PubMed ID: 10342599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
    Leckman JF; Cohen DJ
    Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability profile of clonidine in the treatment of adults with Tourette syndrome.
    Cavanna AE; Selvini C; Termine C; Balottin U; Eddy CM
    Clin Neuropharmacol; 2012; 35(6):269-72. PubMed ID: 23123691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.
    Lombroso PJ; Scahill L; King RA; Lynch KA; Chappell PB; Peterson BS; McDougle CJ; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tics.
    Pringsheim T; Davenport WJ; Lang A
    Curr Opin Neurol; 2003 Aug; 16(4):523-7. PubMed ID: 12869813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.
    Gaffney GR; Perry PJ; Lund BC; Bever-Stille KA; Arndt S; Kuperman S
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):330-6. PubMed ID: 11886028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tics and Tourette syndrome.
    Shaw ZA; Coffey BJ
    Psychiatr Clin North Am; 2014 Sep; 37(3):269-86. PubMed ID: 25150562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case series: clonidine has no systematic effects on PR or QTc intervals in children.
    Kofoed L; Tadepalli G; Oesterheld JR; Awadallah S; Shapiro R
    J Am Acad Child Adolesc Psychiatry; 1999 Sep; 38(9):1193-6. PubMed ID: 10504820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings.
    Gadow KD; Nolan EE; Sverd J
    J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):462-71. PubMed ID: 1592778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of Tourette syndrome: a follow-up study.
    Erenberg G; Cruse RP; Rothner AD
    Ann Neurol; 1987 Sep; 22(3):383-5. PubMed ID: 3479043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
    Niederhofer H; Staffen W; Mair A
    J Psychopharmacol; 2003 Mar; 17(1):113-9. PubMed ID: 12680748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome.
    Sverd J; Gadow KD; Paolicelli LM
    J Am Acad Child Adolesc Psychiatry; 1989 Jul; 28(4):574-9; discussion 580-2. PubMed ID: 2768152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.
    Roessner V; Eichele H; Stern JS; Skov L; Rizzo R; Debes NM; Nagy P; Cavanna AE; Termine C; Ganos C; Münchau A; Szejko N; Cath D; Müller-Vahl KR; Verdellen C; Hartmann A; Rothenberger A; Hoekstra PJ; Plessen KJ
    Eur Child Adolesc Psychiatry; 2022 Mar; 31(3):425-441. PubMed ID: 34757514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.
    Egolf A; Coffey BJ
    Drugs Today (Barc); 2014 Feb; 50(2):159-79. PubMed ID: 24619591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tic reduction with pergolide in a randomized controlled trial in children.
    Gilbert DL; Dure L; Sethuraman G; Raab D; Lane J; Sallee FR
    Neurology; 2003 Feb; 60(4):606-11. PubMed ID: 12601100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.